Hanlin Gao - 30 Jan 2023 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
30 Jan 2023
Transactions value $
-$2,974
Form type
4
Filing time
01 Feb 2023, 17:13:14 UTC
Previous filing
18 Nov 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$2.97K -90 -0.01% $33.04 906K 30 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021.